Old human cells rejuvenated in breakthrough discovery on ageing

November 7, 2017
92 hour time capture image from NHDF cells treated with DMSO and 92 hour time capture image showing NHDF cells treated with resveratrol. Credit: University of Exeter

A team led by Professor Lorna Harries, Professor of Molecular Genetics at the University of Exeter, has discovered a new way to rejuvenate inactive senescent cells. Within hours of treatment the older cells started to divide, and had longer telomeres - the 'caps' on the chromosomes which shorten as we age.

This discovery, funded by the Dunhill Medical Trust, builds on earlier findings from the Exeter group that showed that a class of genes called are progressively switched off as we age. The University of Exeter research team, working with Professor Richard Faragher and Dr Elizabeth Ostler from the University of Brighton, found that splicing factors can be switched back on with chemicals, making senescent not only look physically younger, but start to behave more like young cells and start dividing.

The researchers applied compounds called reversatrol analogues, chemicals based on a substance naturally found in red wine, dark chocolate, red grapes and blueberries, to cells in culture. The chemicals caused splicing factors, which are progressively switched off as we age to be switched back on. Within hours, the cells looked younger and started to rejuvenate, behaving like young cells and dividing.

The research, Small molecule modulation of splicing factor expression is associated with rescue from cellular senescence, is published in the journal, BMC Cell Biology.

The discovery has the potential to lead to therapies which could help people age better, without experiencing some of the degenerative effects of getting old. Most people by the age of 85 have experienced some kind of chronic illness, and as people get older they are more prone to stroke, heart disease and cancer.

Professor Harries said: "This is a first step in trying to make people live normal lifespans, but with health for their entire life. Our data suggests that using chemicals to switch back on the major class of genes that are switched off as we age might provide a means to restore function to old cells."

Dr Eva Latorre, Research Associate at the University of Exeter, who carried out the experiments, was surprised by the extent and rapidity of the changes in the cells.

"When I saw some of the cells in the culture dish rejuvenating I couldn't believe it. These old cells were looking like young cells. It was like magic," she said. "I repeated the experiments several times and in each case the cells rejuvenated. I am very excited by the implications and potential for this research."

As we age, our tissues accumulate which are alive but do not grow or function as they should. These old cells lose the ability to correctly regulate the output of their genes. This is one reason why tissues and organs become susceptible to disease as we age. When activated, genes make a message that gives the instructions for the cell to behave in a certain way. Most genes can make more than one message, which determines how the cell acts.

Splicing factors are crucial in ensuring that genes can perform their full range of functions. One gene can send out several messages to the body to perform a function - such as the decision whether or not to grow new blood vessels - and the splicing factors make the decision about which message to make. As people age, the splicing factors tend to work less efficiently or not at all, restricting the ability of cells to respond to challenges in their environment. Senescent cells, which can be found in most organs from older people, also have fewer splicing factors.

Professor Harries added:

"This demonstrates that when you treat old cells with molecules that restore the levels of the splicing factors, the cells regain some features of youth. They are able to grow, and their telomeres - the caps on the ends of the chromosomes that shorten as we age - are now longer, as they are in young cells. Far more research is needed now to establish the true potential for these sort of approaches to address the degenerative effects of ageing. "

Professor Richard Faragher of the University of Brighton, will today argue for more research into the degenerative effects of ageing in a debate into whether science should be used to extend people's lifespans.

"At a time when our capacity to translate new knowledge about the mechanisms of ageing into medicines and lifestyle advice is limited only by a chronic shortage of funds, older people are ill-served by self-indulgent science fiction. They need practical action to restore their health and they need it yesterday," he said.

Professor Faragher added: "Our discovery of cell rejuvenation using these simple compounds shows the enormous potential of ageing research to improve the lives of "

Explore further: Alternative splicing, an important mechanism for cancer

More information: Eva Latorre et al, Small molecule modulation of splicing factor expression is associated with rescue from cellular senescence, BMC Cell Biology (2017). DOI: 10.1186/s12860-017-0147-7

Related Stories

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

Scientists reverse mechanism of fatty liver disease

June 13, 2017
Researchers have identified the mechanism which causes a build-up of fat in the liver in a disease affecting one in five in the UK—and were able to reverse it in a mouse model.

Researchers extend lifespan by as much as 35 percent in mice

February 3, 2016
Researchers at Mayo Clinic have shown that senescent cells - cells that no longer divide and accumulate with age - negatively impact health and shorten lifespan by as much as 35 percent in normal mice. The results, which ...

Research connects specific variations in RNA splicing with breast cancer causation

October 1, 2015
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.

Recommended for you

Scientists find key to regenerating blood vessels

November 23, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels. The ...

Researchers find infectious prions in Creutzfeldt-Jakob disease patient skin

November 22, 2017
Creutzfeldt-Jakob disease (CJD)—the human equivalent of mad cow disease—is caused by rogue, misfolded protein aggregates termed prions, which are infectious and cause fatal damages in the patient's brain. CJD patients ...

Surprising roles for muscle in tissue regeneration, study finds

November 22, 2017
A team of researchers at Whitehead has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration. In a paper published in the November 22 issue of Nature, they ...

Study reveals new mechanisms of cell death in neurodegenerative disorders

November 22, 2017
Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

5 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

robweeve
1 / 5 (2) Nov 07, 2017
The Koch Bros. must be delighted.
betterexists
not rated yet Nov 07, 2017
Keep injecting animal cells fortified with such analogues in the dishes back to the SAME animals and then check what happens !
baudrunner
5 / 5 (3) Nov 07, 2017
Twice as many men die of heart disease in Britain than in France and the Netherlands. And yet, France and England include equal quantities of fat in their diet. The reason? Red wine with meals.

Red wine contains resveratrol, and the Gers region in France makes wine the old fashioned way, by including skins, seeds, and pedicels in the fermentation. Their wine has astronomically higher resveratrol levels than in conventional wines. The Gers region also boasts the highest per capita population of men of 90 years of age or older in all of Europe.
Whydening Gyre
5 / 5 (1) Nov 07, 2017
FTA;
"compounds called reversatrol analogues,... "
That should read "resveratrol"
But its kinda funny that the typo indicates of what it does...:-)
winthrom
not rated yet Nov 13, 2017
This work is important for the well being of the entire population, not just the aged. The aging population does not die fast enough to relieve the younger population of a heavy load to support the aged both medically and financially. A healthy aged population would lower costs dramatically, and possibly provide a treasure of skill sets needed for modern industry and science. This much is obvious, so the impetuous for this research should reach well up into the geriatric members of congress. Spock had it right: "Live long and Prosper."

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.